Recreational and occupational physical activity in relation to prostate cancer aggressiveness: the North Carolina-Louisiana Prostate Cancer Project (PCaP).

African American Leisure time Occupational physical activity Physical activity Prostate cancer Recreational physical activity

Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 06 10 2021
accepted: 07 03 2022
pubmed: 24 3 2022
medline: 12 5 2022
entrez: 23 3 2022
Statut: ppublish

Résumé

To examine associations between recreational and occupational physical activity and prostate cancer aggressiveness in a population-based, case-only, incident prostate cancer study. Data were analyzed from the cross-sectional North Carolina-Louisiana Prostate Cancer Project of African-American (n = 1,023) and European-American (n = 1,079) men newly diagnosed with prostate cancer (CaP). High-aggressive CaP was defined as Gleason sum ≥ 8, or prostate-specific antigen > 20 ng/ml, or Gleason sum ≥ 7 and clinical stage T3-T4. Metabolic equivalent tasks (MET) were estimated from self-reported recreational physical activity in the year prior to diagnosis assessed retrospectively via a validated questionnaire and from occupational physical activity based on job titles. Associations between physical activity variables and high-aggressive prostate cancer were estimated using logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for multiple confounders. There was suggestive evidence that walking for 75-150 min/week for exercise is associated with lower odds of high-aggressive prostate cancer compared to no walking (OR = 0.69, 95% CI 0.47-1.01). Physical activity at the current job was associated with 24% lower odds of high-aggressive prostate cancer (highest vs. lowest tertile OR = 0.76, 95% CI 0.56-1.04). However, total MET-h/week of recreational physical activity and accumulation of high-level physical activity at the longest-held job were not associated with high-aggressive prostate cancer. Results did not vary by race. The odds of high-aggressive prostate cancer were lower among men who walk for exercise and those engaged in occupations with high activity levels.

Identifiants

pubmed: 35320830
doi: 10.1007/s10552-022-01572-z
pii: 10.1007/s10552-022-01572-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

875-887

Subventions

Organisme : NIGMS NIH HHS
ID : T32-GM081740
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM081740
Pays : United States
Organisme : NCI NIH HHS
ID : R15 CA231510
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL (2019) Cancer statistics for African Americans, 2019. CA Cancer J Clin. https://doi.org/10.3322/caac.21555
doi: 10.3322/caac.21555 pubmed: 31577379
Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics. CA Cancer J Clin 71(1):7–33. https://doi.org/10.3322/caac.21654
doi: 10.3322/caac.21654 pubmed: 33433946
Friedenreich CM, Thune I (2001) A review of physical activity and prostate cancer risk. Cancer Causes Control 12(5):461–475
doi: 10.1023/A:1011210121901
Torti DC, Matheson GO (2004) Exercise and prostate cancer. Sports Med 34(6):363–369
doi: 10.2165/00007256-200434060-00003
Young-McCaughan S (2012) Potential for prostate cancer prevention through physical activity. World J Urol 30(2):167–179. https://doi.org/10.1007/s00345-011-0812-y
doi: 10.1007/s00345-011-0812-y pubmed: 22198724
Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM (2012) Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 104(11):815–840. https://doi.org/10.1093/jnci/djs207
doi: 10.1093/jnci/djs207 pubmed: 22570317 pmcid: 3465697
Anzuini F, Battistella A, Izzotti A (2011) Physical activity and cancer prevention: a review of current evidence and biological mechanisms. J Prev Med Hyg 52(4):174–180
pubmed: 22442921
Liu Y, Hu F, Li D, Wang F, Zhu L, Chen W, Ge J, An R, Zhao Y (2011) Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol 60(5):1029–1044. https://doi.org/10.1016/j.eururo.2011.07.007
doi: 10.1016/j.eururo.2011.07.007 pubmed: 21802197
Kerr J, Anderson C, Lippman SM (2017) Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol 18(8):e457–e471. https://doi.org/10.1016/S1470-2045(17)30411-4
doi: 10.1016/S1470-2045(17)30411-4 pubmed: 28759385
Shephard RJ (2017) Physical activity and prostate cancer: an updated review. Sports Med 47(6):1055–1073. https://doi.org/10.1007/s40279-016-0648-0
doi: 10.1007/s40279-016-0648-0 pubmed: 27844337
Ballon-Landa E, Parsons JK (2018) Nutrition, physical activity, and lifestyle factors in prostate cancer prevention. Curr Opin Urol 28(1):55–61. https://doi.org/10.1097/MOU.0000000000000460
doi: 10.1097/MOU.0000000000000460 pubmed: 29049045
Benke IN, Leitzmann MF, Behrens G, Schmid D (2018) Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis. Ann Oncol 29(5):1154–1179. https://doi.org/10.1093/annonc/mdy073
doi: 10.1093/annonc/mdy073 pubmed: 29788165
Brookman-May SD, Campi R, Henriquez JDS, Klatte T, Langenhuijsen JF, Brausi M, Linares-Espinos E, Volpe A, Marszalek M, Akdogan B, Roll C, Stief CG, Rodriguez-Faba O, Minervini A (2019) Latest evidence on the impact of smoking, sports, and sexual activity as modifiable lifestyle risk factors for prostate cancer incidence, recurrence, and progression: a systematic review of the literature by the European association of urology section of oncological urology (ESOU). Eur Urol Focus 5(5):756–787. https://doi.org/10.1016/j.euf.2018.02.007
doi: 10.1016/j.euf.2018.02.007 pubmed: 29576530
McTiernan A, Friedenreich CM, Katzmarzyk PT, Powell KE, Macko R, Buchner D, Pescatello LS, Bloodgood B, Tennant B, Vaux-Bjerke A, George SM, Troiano RP, Piercy KL, Advisory PAGC (2019) Physical activity in cancer prevention and survival: a systematic review. Med Sci Sports Exerc 51(6):1252–1261. https://doi.org/10.1249/MSS.0000000000001937
doi: 10.1249/MSS.0000000000001937 pubmed: 31095082 pmcid: 6527123
Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, Keadle SK, Arem H, Berrington de Gonzalez A, Hartge P, Adami HO, Blair CK, Borch KB, Boyd E, Check DP, Fournier A, Freedman ND, Gunter M, Johannson M, Khaw KT, Linet MS, Orsini N, Park Y, Riboli E, Robien K, Schairer C, Sesso H, Spriggs M, Van Dusen R, Wolk A, Matthews CE, Patel AV (2016) Association of leisure-time physical activity with risk of 26 types of cancer in 144 million adults. JAMA Internal Med 176(6):816–825. https://doi.org/10.1001/jamainternmed.2016.1548
doi: 10.1001/jamainternmed.2016.1548
Hayes BD, Brady L, Pollak M, Finn SP (2016) Exercise and prostate cancer: evidence and proposed mechanisms for disease modification. Cancer Epidemiol Biomark Prev 25(9):1281–1288. https://doi.org/10.1158/1055-9965.EPI-16-0223
doi: 10.1158/1055-9965.EPI-16-0223
Mordukhovich I, Reiter PL, Backes DM, Family L, McCullough LE, O’Brien KM, Razzaghi H, Olshan AF (2011) A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control 22(3):341–357. https://doi.org/10.1007/s10552-010-9712-5
doi: 10.1007/s10552-010-9712-5 pubmed: 21184263
Grubb RL 3rd, Pinsky PF, Greenlee RT, Izmirlian G, Miller AB, Hickey TP, Riley TL, Mabie JE, Levin DL, Chia D, Kramer BS, Reding DJ, Church TR, Yokochi LA, Kvale PA, Weissfeld JL, Urban DA, Buys SS, Gelmann EP, Ragard LR, Crawford ED, Prorok PC, Gohagan JK, Berg CD, Andriole GL (2008) Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int 102(11):1524–1530. https://doi.org/10.1111/j.1464-410X.2008.08214.x
doi: 10.1111/j.1464-410X.2008.08214.x pubmed: 19035857
Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O’Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13):1310–1319. https://doi.org/10.1056/NEJMoa0810696
doi: 10.1056/NEJMoa0810696 pubmed: 19297565 pmcid: 2944770
Schroeder JC, Bensen JT, Su LJ, Mishel M, Ivanova A, Smith GJ, Godley PA, Fontham ET, Mohler JL (2006) The North Carolina-Louisiana Prostate Cancer Project (PCaP): methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes. Prostate 66(11):1162–1176. https://doi.org/10.1002/pros.20449
doi: 10.1002/pros.20449 pubmed: 16676364
Littman AJ, White E, Kristal AR, Patterson RE, Satia-Abouta J, Potter JD (2004) Assessment of a one-page questionnaire on long-term recreational physical activity. Epidemiology 15(1):105–113. https://doi.org/10.1097/01.ede.0000091604.32542.97
doi: 10.1097/01.ede.0000091604.32542.97 pubmed: 14712154
Littman AJ, Kristal AR, White E (2006) Recreational physical activity and prostate cancer risk (United States). Cancer Causes Control 17(6):831–841. https://doi.org/10.1007/s10552-006-0024-8
doi: 10.1007/s10552-006-0024-8 pubmed: 16783611
Boyle T, Leong S (2012) Comparing ratings of occupational physical activity. Epidemiology 23(6):934–936. https://doi.org/10.1097/EDE.0b013e31826d08e4
doi: 10.1097/EDE.0b013e31826d08e4 pubmed: 23038125
Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS (2011) Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 43(8):1575–1581. https://doi.org/10.1249/MSS.0b013e31821ece12
doi: 10.1249/MSS.0b013e31821ece12 pubmed: 21681120
Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S (2001) Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America’s Table Study. Am J Epidemiol 154(12):1089–1099
doi: 10.1093/aje/154.12.1089
Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, Patel AV, Andrews KS, Bandera EV, Spees CK, Robien K, Hartman S, Sullivan K, Grant BL, Hamilton KK, Kushi LH, Caan BJ, Kibbe D, Black JD, Wiedt TL, McMahon C, Sloan K, Doyle C (2020) American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin 70(4):245–271. https://doi.org/10.3322/caac.21591
doi: 10.3322/caac.21591 pubmed: 32515498
Orsini N, Bellocco R, Bottai M, Pagano M, Andersson SO, Johansson JE, Giovannucci E, Wolk A (2009) A prospective study of lifetime physical activity and prostate cancer incidence and mortality. Br J Cancer 101(11):1932–1938. https://doi.org/10.1038/sj.bjc.6605404
doi: 10.1038/sj.bjc.6605404 pubmed: 19861965 pmcid: 2788257
Patel AV, Rodriguez C, Jacobs EJ, Solomon L, Thun MJ, Calle EE (2005) Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men. Cancer Epidemiol Biomark Prev 14(1):275–279
Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett WC (2005) A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med 165(9):1005–1010. https://doi.org/10.1001/archinte.165.9.1005
doi: 10.1001/archinte.165.9.1005 pubmed: 15883238
Nilsen TI, Romundstad PR, Vatten LJ (2006) Recreational physical activity and risk of prostate cancer: a prospective population-based study in Norway (the HUNT study). Int J Cancer 119(12):2943–2947. https://doi.org/10.1002/ijc.22184
doi: 10.1002/ijc.22184 pubmed: 17019717
Dai JY, Wang B, Wang X, Cheng A, Kolb S, Stanford JL, Wright JL (2019) Vigorous physical activity is associated with lower risk of metastatic-lethal progression in prostate cancer and hypomethylation in the CRACR2A gene. Cancer Epidemiol Biomark Prev 28(2):258–264. https://doi.org/10.1158/1055-9965.EPI-18-0622
doi: 10.1158/1055-9965.EPI-18-0622
Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA (2019) A prospective study of the association between physical activity and risk of prostate cancer defined by clinical features and TMPRSS2:ERG. Eur Urol 76(1):33–40. https://doi.org/10.1016/j.eururo.2018.09.041
doi: 10.1016/j.eururo.2018.09.041 pubmed: 30301696
Moore SC, Peters TM, Ahn J, Park Y, Schatzkin A, Albanes D, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2008) Physical activity in relation to total, advanced, and fatal prostate cancer. Cancer Epidemiol Biomark Prev 17(9):2458–2466. https://doi.org/10.1158/1055-9965.EPI-08-0403
doi: 10.1158/1055-9965.EPI-08-0403
Arab L, Su J, Steck SE, Ang A, Fontham ET, Bensen JT, Mohler JL (2013) Adherence to World Cancer Research Fund/American Institute for Cancer Research lifestyle recommendations reduces prostate cancer aggressiveness among African and Caucasian Americans. Nutr Cancer 65(5):633–643. https://doi.org/10.1080/01635581.2013.789540
doi: 10.1080/01635581.2013.789540 pubmed: 23859030
Shahar S, Shafurah S, Hasan Shaari NS, Rajikan R, Rajab NF, Golkhalkhali B, Zainuddin ZM (2011) Roles of diet, lifetime physical activity and oxidative DNA damage in the occurrence of prostate cancer among men in Klang Valley, Malaysia. Asian Pac J Cancer Prev 12(3):605–611
pubmed: 21627352
Parent ME, Rousseau MC, El-Zein M, Latreille B, Desy M, Siemiatycki J (2011) Occupational and recreational physical activity during adult life and the risk of cancer among men. Cancer Epidemiol 35(2):151–159. https://doi.org/10.1016/j.canep.2010.09.004
doi: 10.1016/j.canep.2010.09.004 pubmed: 21030330
Hrafnkelsdottir SM, Torfadottir JE, Aspelund T, Magnusson KT, Tryggvadottir L, Gudnason V, Mucci LA, Stampfer M, Valdimarsdottir UA (2015) Physical activity from early adulthood and risk of prostate cancer: a 24-year follow-up study among Icelandic men. Cancer Prev Res 8(10):905–911. https://doi.org/10.1158/1940-6207.CAPR-15-0035
doi: 10.1158/1940-6207.CAPR-15-0035
Johnsen NF, Tjonneland A, Thomsen BL, Christensen J, Loft S, Friedenreich C, Key TJ, Allen NE, Lahmann PH, Mejlvig L, Overvad K, Kaaks R, Rohrmann S, Boing H, Misirli G, Trichopoulou A, Zylis D, Tumino R, Pala V, Bueno-de-Mesquita HB, Kiemeney LA, Suarez LR, Gonzalez CA, Sanchez MJ, Huerta JM, Gurrea AB, Manjer J, Wirfalt E, Khaw KT, Wareham N, Boffetta P, Egevad L, Rinaldi S, Riboli E (2009) Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer 125(4):902–908. https://doi.org/10.1002/ijc.24326
doi: 10.1002/ijc.24326 pubmed: 19415749
McTiernan A, Ulrich C, Slate S, Potter J (1998) Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control 9(5):487–509
doi: 10.1023/A:1008853601471
Massengill JC, Sun L, Moul JW, Wu H, McLeod DG, Amling C, Lance R, Foley J, Sexton W, Kusuda LEO, Chung A, Soderdahl D, Donahue T (2003) Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 169(5):1670–1675
doi: 10.1097/01.ju.0000062674.43964.d0
Pekmezi DW, Demark-Wahnefried W (2011) Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol 50(2):167–178. https://doi.org/10.3109/0284186X.2010.529822
doi: 10.3109/0284186X.2010.529822 pubmed: 21091401
Friedenreich CM, Orenstein MR (2002) Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 132(11 Suppl):3456S-3464S
doi: 10.1093/jn/132.11.3456S
Hsing AW, Gao YT, Chua S Jr, Deng J, Stanczyk FZ (2003) Insulin resistance and prostate cancer risk. J Natl Cancer Inst 95(1):67–71
doi: 10.1093/jnci/95.1.67
Barnard RJ, Ngo TH, Leung PS, Aronson WJ, Golding LA (2003) A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate 56(3):201–206. https://doi.org/10.1002/pros.10251
doi: 10.1002/pros.10251 pubmed: 12772189
Gallagher EJ, LeRoith D (2010) The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 21(10):610–618. https://doi.org/10.1016/j.tem.2010.06.007
doi: 10.1016/j.tem.2010.06.007 pubmed: 20663687 pmcid: 2949481
Freedland SJ, Mavropoulos J, Wang A, Darshan M, Demark-Wahnefried W, Aronson WJ, Cohen P, Hwang D, Peterson B, Fields T, Pizzo SV, Isaacs WB (2008) Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 68(1):11–19. https://doi.org/10.1002/pros.20683
doi: 10.1002/pros.20683 pubmed: 17999389 pmcid: 3959866
Pan SY, DesMeules M (2009) Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence. Methods Mol Biol 472:191–215. https://doi.org/10.1007/978-1-60327-492-0_8
doi: 10.1007/978-1-60327-492-0_8 pubmed: 19107434
Saxton JM (2006) Diet, physical activity and energy balance and their impact on breast and prostate cancers. Nutr Res Rev 19(2):197–215. https://doi.org/10.1017/S095442240720294X
doi: 10.1017/S095442240720294X pubmed: 19079886
Su LJ, Arab L, Steck SE, Fontham ET, Schroeder JC, Bensen JT, Mohler JL (2011) Obesity and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study. Cancer Epidemiol Biomark Prev 20(5):844–853. https://doi.org/10.1158/1055-9965.epi-10-0684
doi: 10.1158/1055-9965.epi-10-0684
Ji LL (1999) Antioxidants and oxidative stress in exercise. Exp Biol Med 222(3):283–292
doi: 10.1046/j.1525-1373.1999.d01-145.x
Denvir MA, Gray GA (2009) Run for your life: exercise, oxidative stress and the ageing endothelium. J Physiol 587(17):4137–4138. https://doi.org/10.1113/jphysiol.2009.178624
doi: 10.1113/jphysiol.2009.178624 pubmed: 19720852 pmcid: 2754350
Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44:239–267. https://doi.org/10.1146/annurev.pharmtox.44.101802.121851
doi: 10.1146/annurev.pharmtox.44.101802.121851 pubmed: 14744246

Auteurs

Susan E Steck (SE)

Epidemiology and Biostatistics, and Cancer Prevention and Control Program, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA. stecks@mailbox.sc.edu.
Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, Room 456, Columbia, SC, 29208, USA. stecks@mailbox.sc.edu.

L Joseph Su (LJ)

Department of Epidemiology, Fay W. Boozman College of Public Health, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Samuel O Antwi (SO)

Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.

Bonny B Morris (BB)

Wake Forest Baptist Medical Comprehensive Cancer Center, Winston-Salem, NC, USA.

Brittany Crawford (B)

Epidemiology and Biostatistics, and Cancer Prevention and Control Program, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

Swann Arp Adams (SA)

Epidemiology and Biostatistics, and Cancer Prevention and Control Program, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
College of Nursing, University of South Carolina, Columbia, SC, USA.

James R Hebert (JR)

Epidemiology and Biostatistics, and Cancer Prevention and Control Program, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

Elizabeth T H Fontham (ETH)

School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA.

Jeannette T Bensen (JT)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

James L Mohler (JL)

Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Lenore Arab (L)

David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH